Medical Xpress
Nearly 80% of U.S. neurologists prescribing drugs for multiple sclerosis (MS) have received at least one pharma industry payment, with higher-volume prescribers more likely to be beneficiaries, finds a five-year analysis of Medicare database payments, published in the journal BMJ Open…
Read More
Most US neurologists prescribing multiple sclerosis drugs have received pharma industry cash, analysis finds
Buffy Paris
07:20
Nearly 80% of U.S. neurologists prescribing drugs for multiple sclerosis (MS) have received at least one pharma industry payment, with higher-volume prescribers more likely to be beneficiaries, finds a five-year analysis of Medicare database payments, published in the journal BMJ Open…
